Loading...

Innovation Through Data Partnerships

Thanks to our partner WellteQ, Medibio team members were invited to attend the recent Garmin Health Summit Europe to learn, connect, and share ideas around integration of wearables into business solutions. The power of partnership for innovators like Medibio [...]

2019-09-30T15:51:30-05:00 September 30th, 2019|

Medibio Announces New Board Members and Establishes Growth & Advocacy Advisory Board

MEDIBIO APPOINTS NEW BOARD MEMBERS AND ESTABLISHMENT OF A GROWTH & ADVOCACY ADVISORY BOARD Highlights: ● Mr. Michael Phelps and Mr. Patrick Kennedy have tendered their resignations as Non-Executive Directors of Medibio Limited effective 29 August 2019 as part [...]

2019-09-03T09:46:21-05:00 August 29th, 2019|

Medibio Partners with Digital Corporate Wellness Solution Leader WellteQ

Highlights ● Medibio and WellteQ will work together to implement a unique digital solution incorporating Medibio’s mental well-being assessment into WellteQ’s personalised and holistic wellness platform. ● WellteQ is an award-winning digital wellness solution for personalised health engagement and [...]

2019-07-29T14:03:45-05:00 July 29th, 2019|

Medibio Signs Global Organisation, Compass Group PLC, for the First of Two UK-based Pilots for ilumen™

Highlights: ● Compass employees in its Business and Industry division in the United Kingdom will take part in the ilumen™ well-being pilot commencing in July. ● ilumen™ will provide participants with access to a mobile and web application for [...]

2019-07-01T13:31:52-05:00 July 1st, 2019|

Medibio Algorithm Validated by Study Published in Peer Reviewed Journal

Highlights: ● This study demonstrates that changes in heart rate across sleep-wake states may be valid physiological markers for the identification of depression in a sample of people with sleep complaints. ● The heart rate profiling algorithm classified individuals [...]

2019-06-20T10:20:59-05:00 June 20th, 2019|

Medibio working with DuVal & Associates on Updated Regulatory Strategy

Medibio Announces Regulatory and Commercialisation Strategy Update Melbourne, Australia and Minneapolis, MN – 30 April 2019: Medibio Limited (MEB or the Company)(ASX: MEB)(OTCQB: MDBIF), a mental health technology company provides the following update on regulatory strategy. Effective 29 April, [...]

2019-06-20T10:23:08-05:00 May 16th, 2019|

Medibio Announces Sponsored Research Agreement with Humanitas University

Melbourne, Australia and Minneapolis, MN – 17 April 2019: Medibio Limited (MEB or the Company)(ASX: MEB)(OTCQB: MDBIF), a mental health technology company today announces a Sponsored Research Agreement with the Department of Biomedical Sciences of Humanitas University, Milan, Italy. [...]

2019-05-16T16:12:29-05:00 April 17th, 2019|

Medibio Signs Insurance Company AIA Australia Ltd (AIAA) For an Exclusive Pilot Program For ilumen™

Sydney, Australia and Minneapolis, MN USA – 27 November 2018: Medibio Limited (MEB or the Company)(ASX: MEB)(OTCQB: MDBIF), a mental health technology company announces that it has signed an exclusive agreement with AIAA to undertake a pilot program for [...]

2019-03-13T13:59:54-05:00 November 26th, 2018|